LeadIQ logo
Learn more at LeadIQ.com

Insights

Market Expansion Potential Allergy Therapeutics has a well-established commercial presence in Europe and is now focusing on the US market, presenting an opportunity for sales expansion into a new geographic region with high market potential.

Product Pipeline Growth With a pipeline of allergy vaccines in clinical development, including treatments for grass, tree, and house dust mite allergies, there are opportunities to target healthcare providers and patients seeking innovative allergy treatment solutions.

Key Personnel Additions Recent appointments of David Ball as an independent Non-Executive Director and Shaun Furlong as an Executive Director bring new expertise to the leadership team, potentially opening doors for strategic partnerships and collaborations that can drive sales growth.

Financial Stability Successfully raising $50.2 million in equity financing demonstrates financial stability, providing a strong foundation for potential investors and partners to engage with Allergy Therapeutics, boosting sales opportunities through increased investment potential.

Industry Presence Showcase Participation in prominent events like the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization (AAAAI/WAO) Joint Congress provides a platform to showcase their latest research, enhance brand visibility, and attract potential clients and collaborators in the industry.

Similar companies to Allergy Therapeutics

Allergy Therapeutics Tech Stack

Allergy Therapeutics uses 8 technology products and services including Google Font API, yepnope.js, jQuery, and more. Explore Allergy Therapeutics's tech stack below.

  • Google Font API
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Microsoft Azure
    Platform As A Service
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • X-Content-Type-Options
    Web & Portal Technology
  • AddToAny
    Widgets

Media & News

Allergy Therapeutics's Email Address Formats

Allergy Therapeutics uses at least 1 format(s):
Allergy Therapeutics Email FormatsExamplePercentage
First.Last@allergytherapeutics.comJohn.Doe@allergytherapeutics.com
91%
First.Middle@allergytherapeutics.comJohn.Michael@allergytherapeutics.com
4%
FirstLast@allergytherapeutics.comJohnDoe@allergytherapeutics.com
3%
FLast@allergytherapeutics.comJDoe@allergytherapeutics.com
2%

Frequently Asked Questions

Where is Allergy Therapeutics's headquarters located?

Minus sign iconPlus sign iconAllergy Therapeutics's main headquarters is located at Dominion Way Worthing, West Sussex BN14 8SA GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Allergy Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Allergy Therapeutics's main corporate office by phone at
+44-1903-84****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Allergy Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAllergy Therapeutics's official website is allergytherapeutics.com and has social profiles on LinkedIn.

How much revenue does Allergy Therapeutics generate?

Minus sign iconPlus sign icon As of April 2025, Allergy Therapeutics's annual revenue reached $750M.

What is Allergy Therapeutics's NAICS code?

Minus sign iconPlus sign iconAllergy Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Allergy Therapeutics have currently?

Minus sign iconPlus sign iconAs of April 2025, Allergy Therapeutics has approximately 501 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer (cco): R. K.Chief Scientific Officer: M. S.Chief Financial Officer: S. F.. Explore Allergy Therapeutics's employee directory with LeadIQ.

What industry does Allergy Therapeutics belong to?

Minus sign iconPlus sign iconAllergy Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Allergy Therapeutics use?

Minus sign iconPlus sign iconAllergy Therapeutics's tech stack includes Google Font APIyepnope.jsjQueryMicrosoft AzureX-XSS-ProtectionGoogle Tag ManagerX-Content-Type-OptionsAddToAny.

What is Allergy Therapeutics's email format?

Minus sign iconPlus sign iconAllergy Therapeutics's email format typically follows the pattern of . Find more Allergy Therapeutics email formats with LeadIQ.

How much funding has Allergy Therapeutics raised to date?

Minus sign iconPlus sign icon As of April 2025, Allergy Therapeutics has raised $30M in funding. The last funding round occurred on Mar 12, 2015 for $30M.

When was Allergy Therapeutics founded?

Minus sign iconPlus sign iconAllergy Therapeutics was founded in 1998.
Allergy Therapeutics

Allergy Therapeutics

Pharmaceutical ManufacturingWest Sussex, United Kingdom501-1000 Employees

Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. 

We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development.

Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.

Section iconCompany Overview

Headquarters
Dominion Way Worthing, West Sussex BN14 8SA GB
Phone number
+44-1903-84****
Website
allergytherapeutics.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1998
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $30M

    Allergy Therapeutics has raised a total of $30M of funding over 1 rounds. Their latest funding round was raised on Mar 12, 2015 in the amount of $30M.

  • $100M$1B

    Allergy Therapeutics's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $30M

    Allergy Therapeutics has raised a total of $30M of funding over 1 rounds. Their latest funding round was raised on Mar 12, 2015 in the amount of $30M.

  • $100M$1B

    Allergy Therapeutics's revenue is in the range of $100M$1B

Company Leadership

  • Stylized image of a person
    R. K.
    Chief Commercial Officer (cco)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. S.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. F.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. F. F.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. A.
    Head Of Data Management And Analytics
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. F. F.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. W.
    Interim Head Of Analytical Technology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. A.
    Head Of Data Management And Analytics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. B.
    Head Of Business Innovation
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. A.
    Head Of Production
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.